Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elan
Pharma
GlaxoSmithKline nabs EU nod for Relvar in asthma; Elan shareholders give final blessing to Perrigo buyout;
@FiercePharma: The weekend's best-read special report: Top Pharma Companies by 2012 Revenues. Read | Follow @FiercePharma @EricPFierce: Pfizer gives BlackBerry the raspberry. Piece | Follow...
Tracy Staton
Nov 18, 2013 12:03pm
Elan buys share of Theravance royalties on new drug for $1B; Vivus bulks up its board in anticipation of proxy fight;
May 13, 2013 11:29am
Celgene, Elan settle Abraxane case for $78M; Health groups ask Novartis to back off Gleevec patent;
Feb 25, 2011 11:00am
